Bafna Pharmaceuticals Ltd (BAFNAPHARM):企業の財務・戦略的SWOT分析

◆英語タイトル:Bafna Pharmaceuticals Ltd (BAFNAPHARM) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15141
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bafna Pharmaceuticals Ltd (Bafna Pharmaceuticals) is a pharmaceutical company that manufactures and markets medicinal products. The company provides operations such as domestic marketing, international marketing, international export and business development, among others. It offers products such as raricap, raricap forte, raricap L suspension, raricapcombi, and others. Bafna Pharmaceuticals has instruments for research and development such as fluidised bed processor, retsch drier, RMG, bin blender, compression machine5 station, B tooling and 5 station D tooling, coating machine and blister alu semi-automatic packing machine, among others. The company operates manufacturing facilities in Chennai. It supplies products in India, Sri Lanka, the Philippines, Vietnam, Singapore, the UK, Australia, and others. Bafna Pharmaceuticals is headquartered in Chennai, Tamil Nadu, India.

Bafna Pharmaceuticals Ltd Key Recent Developments

May 28,2018: Bafna Pharmaceuticals: Intimation of UK MHRA Approval – Renewal

This comprehensive SWOT profile of Bafna Pharmaceuticals Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Bafna Pharmaceuticals Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Bafna Pharmaceuticals Ltd – Key Information
Bafna Pharmaceuticals Ltd – Overview
Bafna Pharmaceuticals Ltd – Key Employees
Bafna Pharmaceuticals Ltd – Key Employee Biographies
Bafna Pharmaceuticals Ltd – Key Operational Heads
Bafna Pharmaceuticals Ltd – Major Products and Services
Bafna Pharmaceuticals Ltd – History
Bafna Pharmaceuticals Ltd – Company Statement
Bafna Pharmaceuticals Ltd – Locations And Subsidiaries
Bafna Pharmaceuticals Ltd – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Bafna Pharmaceuticals Ltd – Business Description
Bafna Pharmaceuticals Ltd – Corporate Strategy
Bafna Pharmaceuticals Ltd – SWOT Analysis
SWOT Analysis – Overview
Bafna Pharmaceuticals Ltd – Strengths
Bafna Pharmaceuticals Ltd – Weaknesses
Bafna Pharmaceuticals Ltd – Opportunities
Bafna Pharmaceuticals Ltd – Threats
Bafna Pharmaceuticals Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Bafna Pharmaceuticals Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Bafna Pharmaceuticals Ltd, Key Information
Bafna Pharmaceuticals Ltd, Key Ratios
Bafna Pharmaceuticals Ltd, Share Data
Bafna Pharmaceuticals Ltd, Major Products and Services
Bafna Pharmaceuticals Ltd, History
Bafna Pharmaceuticals Ltd, Key Employees
Bafna Pharmaceuticals Ltd, Key Employee Biographies
Bafna Pharmaceuticals Ltd, Key Operational Heads
Bafna Pharmaceuticals Ltd, Other Locations
Bafna Pharmaceuticals Ltd, Subsidiaries
Bafna Pharmaceuticals Ltd, Key Manufacturing facilities
Bafna Pharmaceuticals Ltd, Key Competitors
Bafna Pharmaceuticals Ltd, SWOT Analysis
Bafna Pharmaceuticals Ltd, Ratios based on current share price
Bafna Pharmaceuticals Ltd, Annual Ratios
Bafna Pharmaceuticals Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Bafna Pharmaceuticals Ltd, Performance Chart
Bafna Pharmaceuticals Ltd, Ratio Charts

★海外企業調査レポート[Bafna Pharmaceuticals Ltd (BAFNAPHARM):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Universities Superannuation Scheme Ltd:企業の戦略的SWOT分析
    Universities Superannuation Scheme Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Cocrystal Pharma Inc (COCP):企業の財務・戦略的SWOT分析
    Summary Cocrystal Pharma Inc (Cocrystal Pharma), formerly Biozone Pharmaceuticals Inc, a subsidiary of MusclePharm Corp, is a clinical stage biotechnology company that discovers and develops novel antiviral therapeutics. The company provides treatments for chronic viral diseases. Its pipeline produc …
  • Chico’s FAS Inc:戦略・SWOT・企業財務分析
    Chico's FAS Inc - Strategy, SWOT and Corporate Finance Report Summary Chico's FAS Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • numares AG:企業の製品パイプライン分析2018
    Summary Numares AG (Numares), formerly Numares GmbH, is a developer and marketer of products for life science research and clinical diagnostics. The company’s AXINON lipoFIT, a test system used for lipoprotein profiling, while insightLP provides insights into lipid related research using lipoprotein …
  • The Madison Square Garden Co:企業の戦略・SWOT・財務情報
    The Madison Square Garden Co - Strategy, SWOT and Corporate Finance Report Summary The Madison Square Garden Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Transat A.T. Inc:戦略・SWOT・企業財務分析
    Transat A.T. Inc - Strategy, SWOT and Corporate Finance Report Summary Transat A.T. Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Solocal Group (LOCAL):企業の財務・戦略的SWOT分析
    Solocal Group (LOCAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Enerplus Corp (ERF):企業の財務・戦略的SWOT分析
    Summary Enerplus Corp (Enerplus), formerly Enerplus Resources Fund is an oil and gas company that offers exploration and development services. The company provides exploration and development of natural resource properties for the production of crude oil, light and heavy oil, natural gas, and shallo …
  • Blount International, Inc.:企業の戦略的SWOT分析
    Blount International, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Spirit AeroSystems Holdings, Inc.:企業のM&A・事業提携・投資動向
    Spirit AeroSystems Holdings, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Spirit AeroSystems Holdings, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • Celsia SA ESP (CELSIA):企業の財務・戦略的SWOT分析
    Summary Celsia SA ESP (Celsia), formerly Compania Colombiana de Inversiones SA ESP, a subsidiary of Grupo Argos SA, is an energy company that generates, transmits, distributes, and sells electricity. The company’s product categories include home line, solar energy, backup energy, thermal network, ef …
  • Phosphagenics Ltd:企業のM&A・事業提携・投資動向
    Phosphagenics Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Phosphagenics Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • U.S. Bancorp:戦略・SWOT・企業財務分析
    U.S. Bancorp - Strategy, SWOT and Corporate Finance Report Summary U.S. Bancorp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Euronet Worldwide Inc (EEFT):企業の財務・戦略的SWOT分析
    Euronet Worldwide Inc (EEFT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • FUJIFILM Holdings Corporation:企業の戦略・SWOT・財務分析
    FUJIFILM Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary FUJIFILM Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Consolidated Edison Company of New York, Inc.:発電所・企業SWOT分析
    Consolidated Edison Company of New York, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, in …
  • OctreoPharm Sciences GmbH-医療機器分野:企業M&A・提携分析
    Summary OctreoPharm Sciences GmbH (OPS), a subsidiary of Ipsen SA is a clinical development biopharmaceutical company that develops radiopharmaceuticals for the diagnosis and therapeutic control of tumors. The company develops theranostic couple of antagonistic peptides for the diagnosis and treatme …
  • Curevac AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Curevac AG (Curevac), formerly CureVac GmbH is a clinical-stage biopharmaceutical company that develops RNA-based medicines. The company develops, designs, and produces messenger RNA molecules for therapeutic and prophylactic vaccines in the fields of oncology and infectious diseases. Its RN …
  • Atrium Innovations Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Atrium Innovations Inc (Atrium) is a provider of science-based natural health products. The company develops, manufactures and markets nutritional and dietary supplements. Its major products include minerals, vitamins and specialized products such as enzymes and probiotics. Atrium markets it …
  • Shandong Weigao Group Medical Polymer Company Ltd (1066)-医療機器分野:企業M&A・提携分析
    Summary Shandong Weigao Group Medical Polymer Company Ltd (Weigao) researches, develops, manufactures and sells disposable medical consumables, orthopedic materials and blood purification products. Its products include infusion sets, needles, blood bags, heart eluting stents, blood sampling products …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆